Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Touchstone commits funds to Ieso Digital Health

12 Sep 2017 07:00

RNS Number : 4276Q
Touchstone Innovations PLC
12 September 2017
 

 

12 September 2017

 

Touchstone Innovations plc

 

Touchstone commits £8m in £18m funding round in Ieso Digital Health

 

Touchstone Innovations plc (AIM: IVO, 'the Group', 'Touchstone') has co-led a £18.0 million funding round in Ieso Digital Health ("Ieso" or "the Company"), the UK's leading provider of online Cognitive Behavioural Therapy (CBT) for the treatment of people suffering from community based mental healthcare conditions, predominantly depression and anxiety.

 

Touchstone has committed £8.0 million to the round, including a loan of £2.0 million from May 2017, which has now converted to equity. Touchstone invested alongside new investor Draper Esprit, who co-led the round, together with existing investor Ananda Social Venture Fund and a number of business angels.

 

Ieso, based in Cambridge, is the largest provider of online CBT in the UK. By the end of 2017, Ieso will have delivered over 100,000 hours of therapy to more than 16,700 patients, within the 9 million patients who have access via clinical commissioning contracts. The Company's proprietary web-based platform provides patients with access to CBT, delivered in real-time by accredited therapists utilising written (typed) conversation directly accessible from their computer, tablet or smartphone.

 

Therapy delivered in this way has been clinically validated in routine NHS service to deliver better results than traditional face-to-face methods, with higher levels of access, patient engagement, therapy session completion and lower drop-out rates. 

 

The new funding will enable Ieso to continue to grow its UK business and accelerate its introduction and expansion in the US, where the Company has achieved significant early traction and recently appointed a new highly-experienced management team.

 

As at 31 January 2017, the Group had a 46.9% interest in the issued share capital of Ieso. Following this new investment Touchstone will hold a 49.3% interest in the Company.

 

Commenting on this funding round, Dan Clark, CEO of Ieso said:

 

"Ieso is creating transformative change in mental health treatment.

 

"An estimated 60% of patients do not seek out mental health services, largely because of stigma and difficulty in accessing care. We've helped eliminate these barriers and are empowering patients by delivering therapy at a time that fits their lifestyles and through devices that are a part of their everyday lives.

 

"This new funding will allow us to continue scaling geographically and innovating our technology by applying artificial intelligence and machine learning to enhance therapist support and further improving patient access."

 

Inga Deakin, Principal at Touchstone and Ieso Board member added:

 

"We first invested in Ieso in 2013. From the outset, we believed that the best way to nurture the business was to demonstrate traction in the UK National Health Service, which has a world-leading CBT delivery infrastructure and ambitious targets for delivery of treatment to patients.

 

"With more than 16,700 patients treated, Ieso has developed outstanding clinical credentials and built a strong evidenced-based platform. The Company has also assembled a highly-experienced management team, comprising world-class artificial intelligence and data scientists, clinicians, therapists and executive leadership.

 

"This new funding round is the largest amount raised by a digital behavioural health business in Europe and will enable the next phase of growth."

 

For further information contact:

 

Touchstone Innovations plc

020 3053 8834

Russ Cummings, Chief Executive Officer

 

Jon Davies, Director of Communications

 

 

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Melanie Toyne-Sewell/Chantal Woolcock

 

 

 

J.P. Morgan Cazenove (Nominated Adviser)

020 7742 4000

Michael Wentworth-Stanley/Alec Pratt

 

 

 

RBC Capital Markets

020 7653 4000

Darrell Uden/Marcus Jackson/Laura White

 

 

About Touchstone Innovations - www.touchstoneinnovations.com

 

Touchstone Innovations plc (formerly Imperial Innovations Group plc) creates, builds and invests in pioneering technology companies and licensing opportunities developed from outstanding scientific research from the 'Golden Triangle', the geographical region broadly bounded by London, Cambridge and Oxford.

 

This area has an unrivalled cluster of outstanding academic research and technology businesses, and is home to four of the world's top 10 universities, as well as leading research institutions, the cream of the UK's science and technology businesses and many of its leading investors.

 

Touchstone supports scientists and entrepreneurs in the commercialisation of their ideas through protecting and licensing out intellectual property (through its Technology Transfer subsidiary, Imperial Innovations Limited), by leading the formation of new companies, by recruiting high calibre management teams and by providing investment and encouraging co-investment. Touchstone remains an active investor over the life of its portfolio companies, with the majority of its investment going into businesses in which it is already a shareholder.

 

Since becoming a public company in 2006, Touchstone has raised more than £440 million of equity from investors, which has enabled it to invest in some of the most exciting spin-outs to come out of UK academic research. In addition, the Group has drawn down the outstanding £50.0 million from the European Investment Bank (EIB) taking the total loan to £80.0 million.

 

Between admission to AIM (August 2006) and 30 June 2017, Touchstone has invested a total of £364.0 million across its portfolio companies, which have collectively raised investment of more than £1.5 billion.

 

About Ieso Digital Health - https://uk.iesohealth.com/

 

Ieso Digital Health (Ieso) offers real-time one-to-one therapy online for people dealing with depression and anxiety. The Company's proprietary web-based platform enables Cognitive Behavioural Therapy (CBT) to be delivered in real-time by real therapists using written (typed) conversation.

 

Ieso is the largest provider of online CBT in the UK, and has treated more than 16,700 patients and captured over 75 million clinical data units in the company's therapy database. These data are then analysed, with the findings being used to support continuous improvement in the product and in the therapists' performance.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSRAFILLID
Date   Source Headline
7th Jun 20177:00 amRNSForm 8 (OPD) IP Group PLC
6th Jun 201711:19 amRNSForm 8.3 - Touchstone Innovations
5th Jun 201712:46 pmRNSForm 8.3 - Touchstone Innovations Plc
1st Jun 20172:41 pmBUSForm 8.3 - Touchstone Innovations plc
1st Jun 20177:00 amRNSChairman's letter to shareholders
31st May 20175:58 pmRNSForm 8.5 (EPT/RI) - Touchstone Innovations Plc
31st May 201712:01 pmRNSForm 8.3 - Touchstone Innovations Plc
30th May 20177:00 amRNSForm 8.3 - Touchstone Innovations Plc
26th May 201712:29 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:15 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:14 pmRNSForm 8.3 - Touchstone Innovations Plc
25th May 201712:10 pmRNSForm 8.3 - IP Group Plc
24th May 20172:55 pmRNSForm 8.3 - IP Group plc
24th May 20172:52 pmRNSForm 8.3 - Touchstone Innovations plc
24th May 20172:51 pmRNSForm 8.3 - IP Group Plc
24th May 20172:41 pmRNSForm 8.3 - Touchstone Innovations Plc
24th May 20171:15 pmRNSForm 8.3 - Touchstone Innovations Plc
24th May 201711:17 amBUSForm 8 (DD) - Touchstone Innovations Plc.
23rd May 201712:05 pmRNSUpdate on possible offer
23rd May 201711:45 amRNSForm 8.3 - Touchstone Innovations Plc
23rd May 201710:33 amRNSStatement re Possible Offer
23rd May 20177:01 amRNSStatement re Possible Offer
21st Apr 201711:21 amRNSInnovations invests £2.9m in Abzena placing
6th Apr 20177:00 amRNSInnovations provides seed funding for Cardian
31st Mar 20177:00 amRNSHalf Yearly Report
20th Mar 20177:05 amRNSInnovations supports funding round in Pulmocide
16th Mar 20177:00 amRNSInnovations invests in Cell Medica funding round
14th Mar 20177:00 amRNSInnovations supports funding round in Resolver
6th Mar 20177:00 amRNSInnovations leads £12m funding round in Garrison
28th Feb 201711:11 amRNSNotice of Results
21st Feb 20177:03 amRNSCell Medica granted FDA Fast Track designation
26th Jan 20172:00 pmRNSDirectorate Change
5th Jan 20177:00 amRNSChange of name to Touchstone Innovations plc
4th Jan 20179:00 amRNSAppointment of Joint Broker
20th Dec 201612:03 pmRNSPsiOxus signs exclusive licence agreement with BMS
28th Nov 20167:02 amRNSPortfolio company TopiVert receives IND approval
23rd Nov 20165:56 pmRNSGrant of share options
21st Nov 201612:53 pmRNSResult of AGM
28th Oct 201612:30 pmRNSProposed change of name to Touchstone Innovations
28th Oct 201612:29 pmRNSPosting of Annual Report and Notice of AGM
24th Oct 20167:12 amRNSVeryan announces completion of subject enrolment
13th Oct 20167:00 amRNSFinal Results
10th Oct 20161:02 pmRNSCrescendo Biologics sign collaboration with Takeda
6th Oct 20167:02 amRNSFirst patients dosed in TopiVert's Phase IIa study
3rd Oct 201612:10 pmRNSSale of Innovations portfolio company Permasense
21st Sep 20167:06 amRNSInnovations invests £5.1m in Artios Pharma Limited
14th Sep 201612:02 pmRNSNotice of Results
13th Sep 20164:08 pmRNSTR-1: Notification of major interest in shares
9th Sep 20161:15 pmRNSHolding(s) in Company
6th Sep 20164:17 pmRNSEdison issues update on Imperial Innovations (IVO)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.